Search Results for "Sensipar"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Sensipar. Results 1 to 2 of 2 total matches.
See also: cinacalcet
Cinacalcet (Sensipar)
The Medical Letter on Drugs and Therapeutics • Sep 20, 2004 (Issue 1192)
Cinacalcet (Sensipar) ...
Cinacalcet hydrochloride (Sensipar - Amgen) has been approved by the FDA for treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis and treatment of hypercalcemia in patients with parathyroid carcinoma.
Extended-Release Calcifediol (Rayaldee) for Secondary Hyperparathyroidism
The Medical Letter on Drugs and Therapeutics • Feb 27, 2017 (Issue 1515)
. Clin J
Am Soc Nephrol 2011; 6:913.
2. Cinacalcet (Sensipar). Med Lett Drugs Ther 2004; 46:80.
3. SN ...
The FDA has approved extended-release (ER)
calcifediol (25-hydroxyvitamin D3; Rayaldee –
Opko), a prohormone of calcitriol, the active form of
vitamin D3. It is indicated for treatment of secondary
hyperparathyroidism (SHPT) in adults with stage 3 or
4 chronic kidney disease (CKD) who have serum total
25-hydroxyvitamin D levels <30 ng/mL.